Valeant: Out of the Frying Pan, Into the Fire
June 27, 2017 at 14:02 PM EDT
Wells Fargo analyst David Maris weighs in on why a debt-to-equity swap won't end the troubles facing Valeant Pharmaceuticals International.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.